A new study suggests that clearing aging brain cells dramatically reduces seizures and improves memory in mice with temporal lobe epilepsy, according to researchers at Georgetown University Medical Center. The research points to a fresh pathway for treating epilepsy, especially in individuals who do not respond to existing medication.

What the study examined

Temporal lobe epilepsy (TLE) causes repeated seizures and often disrupts memory and thinking. Scientists observed that certain brain support cells, called glial cells, showed signs of early aging in affected brain regions. These aging cells were found at much higher levels in brain tissue taken from human patients.

To test whether these aging cells contribute to epilepsy, researchers used a mouse model of TLE. They found that markers of cell aging increased within two weeks after inducing the brain injury that triggers epilepsy.

Experimental approach and results

The research team used two methods to remove the aging cells in mice:

• Genetic techniques that specifically targeted aged glial cells
• Drug-based treatment using a combination of known compounds

After treatment, the number of senescent, or aged, cells in the brain dropped by about 50%. Treated mice showed remarkable changes: ScienceDaily

• Fewer epileptic seizures
• Improved performance in memory tests
• About one-third of the mice did not develop epilepsy at all

Why this matters

“A third of individuals living with epilepsy don’t achieve freedom from seizures with current medications,”
said Dr. Patrick A. Forcelli, lead author and professor at the Department of Pharmacology & Physiology.
“Our hope is that senotherapy, which involves using medications to remove aging cells, could potentially minimize the need for surgery and/or improve outcomes after surgery.”

The drugs used in this study — dasatinib (a leukemia therapy) and quercetin (a plant flavonoid) — have known safety profiles and are already being evaluated in other clinical settings. Because of this, scientists say the path to human testing could be faster than typical new therapies.

Potential implications and next steps

The findings suggest that senescent glial cells may play a role in the development and persistence of epilepsy. They also link this process to broader aspects of brain aging and neurological disease, such as Alzheimer’s.

Researchers plan to extend this work by studying how timing and dose affect outcomes, and by exploring whether similar approaches could benefit humans. They also intend to test the effects of other drugs that target cell aging in the brain.

Scientific context

This research was supported by grants from the National Institutes of Health (NIH) and published in the peer-reviewed journal Annals of Neurology. It adds to a growing field that investigates how cellular aging (senescence) influences neurological disorders.